Skip to main content
Annals of Intensive Care

Table 2 Symptoms, laboratory and electrocardiogram findings, and sequential organ failure assessment scores, on the day of the acute myocardial infarction according to occurrence of composite outcome components

From: In-hospital outcomes after acute myocardial infarction with obstructive coronary artery disease in critically ill patients hospitalized for non-cardiac disease

Variable

Total

(n = 96)

Severe ischemic eventa

Major bleeding eventb

All cause death

Yes

(n = 17)

No

(n = 79)

Yes

(n = 26)

No

(n = 70)

Yes

(n = 26)

No

(n = 70)

Typical chest pain

28 (29)

5 (29)

23 (29)

9 (35)

19 (27)

4 (15)

24 (34)

Cardiogenic shock

24 (25)

4 (23)

20 (25)

4 (15)

20 (29)

13 (50)*

11 (16)*

Electrocardiogram changes

87 (91)

17 (100)

70 (89)

23 (88)

64 (91)

65 (93)

22 (85)

 STEMI

35 (37)

5 (29)

30 (38)

6 (23)

29 (41)

8 (31)

27 (39)

   ST segment elevation

31 (32)

4 (23)

27 (34)

6 (23)

25 (36)

6 (23)

25 (36)

   New onset left bundle branch block

5 (5)

2 (12)

3 (4)

1 (4)

4 (6)

2 (8)

3 (4)

 ST segment depression

37 (39)

9 (53)

28 (35)

12 (46)

25 (36)

7 (27)

30 (43)

 T wave inversion

39 (41)

10 (59)

29 (37)

11 (42)

28 (40)

8 (31)

31 (44)

 Q wave

14 (15)

1 (6)

13 (16)

2 (8)

12 (17)

3 (11)

11 (16)

Laboratory findings

       

 Cardiac troponin, times the URLc

62 [15–190]

62 [24–124]

61 [12–194]

53 [10–203]

64 [16–173]

61 [16–161]

80 [12–215]

 Cardiac troponin peak, times the URLc

131 [44–303]

173 [50–236]

126 [39–319]

163 [46–301]

125 [43–301]

131 [49–258]

138 [17–394]

 Hematocrit, % (MD = 6)

34 [28–40]

30 [27–39]

35 [28–41]

28 [25–34]*

35 [30–41]

32 [28–35]

35 [28–41]

 Platelets, 103/mm3 (MD = 1)

221 [175–291]

204 [140–274]

224 [178–303]

213 [143–284]

225 [181–310]

195 [127–265]*

224 [191–310]

 Plasma creatinine, µmol/L ( MD = 2)

130 [91–196]

146 [96–207]

129 [86–189]

134 [89–296]*

127 [92–174]

144 [101–235]

120 [90–186]

 PH (MD = 3)

7.34 [7.22–7.42]

7.37 [7.29–7.41]

7.34 [7.20–7.42]

7.36 [7.31–7.42]

7.33 [7.20–7.42]

7.35 [7.22–7.41]

7.34 [7.21–7.42]

 PaO2/FiO2 ratio (MD = 5)

222 [149–337]

189 [157–405]

228 [148–330]

203 [133–305]

223 [151–337]

199 [148–247]

234 [152–349]

 Lactate, mmol/L (MD = 6)

2.5 [1.5–4.6]

2.1 [1.5–4.5]

2.6 [1.5–4.6]

1.9 [1.4–3.8]

3.0 [1.6–5.2]

3.1 [1.6–7.4]

2.4 [1.4–4.1]

Left ventricular systolic dysfunction, (LVEF ≤ 45%), No. (%) (MD = 26)

50 (70)

9 (53)

41 (52)

12 (46)

38 (54)

39 (56)

11 (42)

TIMI risk scored

4 [3–5]

4 [3–5]

4 [3–5]

4 [3–5]

4 [3–5]

4 [3–5]

4 [3–5]

SOFA global score

8 [3–11]

9 [4–12]

7 [3–11]

6 [4–11]

8 [3–11]

10 [8–12]*

5 [2–10]

SOFA Cardiovascular score

2 [0–4]

4 [0–4]

1 [0–4]

1 [0–4]

4 [0–4]

4 [4–4] *

1 [0–4]

  1. Continuous variables are medians [25th–75th percentile]. Categorical variables are numbers (percentages)
  2. Abbreviations: LVEF: left ventricular ejection fraction; MD: missed data; SOFA: sequential organ failure assessment; STEMI: ST elevation myocardial infarction; TIMI: Thrombolysis in Myocardial Infarction; URL, upper reference limit
  3. a Composite of acute myocardial infarction recurrence and stroke
  4. b According to the Bleeding Academic Research Consortium [25]
  5. c The URL (different for each center) corresponding to the 99th percentile value for the overall population. More details in Additional file 1, Table S1
  6. d Derived in patients with non-ST-segment elevation myocardial infarction to predict 14-day outcomes, including all-cause mortality, new or recurrent myocardial infarction or severe recurrent ischaemia requiring urgent revascularization [23]
  7. * Univariate comparison with p < 0.05
Back to article page